ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
2.920
+0.020 (0.69%)
At close: Oct 16, 2025, 4:00 PM EDT
2.980
+0.060 (2.05%)
After-hours: Oct 16, 2025, 5:34 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $66.61 million as of October 16, 2025. Its market cap has increased by 683.63% in one year.
Market Cap
66.61M
Enterprise Value
67.15M
1-Year Change
683.63%
Ranking
Category
Stock Price
$2.92
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $66.61M, a decrease of -16.22%. That is a compound annual growth rate of -4.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 68.30M | 787.01% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.52B |
| Johnson & Johnson | 461.94B |
| AbbVie | 400.99B |
| UnitedHealth Group | 322.09B |
| AstraZeneca | 262.65B |
| Novartis AG | 253.93B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 221.60B |